𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A combination therapy of continuous superselective intraarterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma : A Phase I study

✍ Scribed by Nobukazu Fuwa; Yoshiyuki Ito; Akira Matsumoto; Minoru Kamata; Takesi Kodaira; Kazuhisa Furutani; Masahiro Sasaoka; Yasuo Kimura; Kozo Morita

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
128 KB
Volume
89
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A Phase I/II study of external beam radi
A Phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207) : Final report
✍ Laurie E. Gaspar; Kathryn Winter; Walter I. Kocha; Lawrence R. Coia; Arnold Hers πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 2 views

## Background: A multiinstitutional, prospective study of the radiation therapy oncology group (rtog) was designed to determine the feasibility and toxicity of chemotherapy, external beam radiation, and esophageal brachytherapy (eb) in a potentially curable group of patients with adenocarcinoma or

Hyperfractionated radiation therapy and
Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (Β± granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma
✍ AndrΓ© A. Abitbol; Kasi S. Sridhar; Alan A. Lewin; James G. Schwade; William Raub πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 166 KB πŸ‘ 2 views

initial entry of 34 patients. Cancer Center, University of Miami School of RESULTS. At a median follow-up of 41 months (range, 12-80 months), 44 patients Medicine, Miami, Florida. were alive with a projected median overall survival of 54 months. Grade 3/4 muco-2 Regional Cancer Center, Baptist Hosp